More promise for Patients as a result of the innovation coming out of New Jersey’s life sciences ecosystem…
BioNJ President and CEO Debbie Hart was named to a list of 38 “Women of Power” in the most recent issue of HudsonMOD along with Diane Von Furstenberg, Ivanka Trump, Sandra E. Peterson, Sheri McCoy, Nina Mitchell Wells, Barbara Corcoran and Beyonce Knowles. Hart was quoted as saying: “New Jersey is poised to realize its full potential as an important location for biotechnology and life sciences.”
BioNJ Member Eli Lilly and Company and Boehringer Ingelheim Pharmaceuticals announced that the FDA granted approval for Basaglar® (insulin glargine injection) 100 units/mL. Basaglar® is indicated to control high blood sugar in adults and children with type 1 diabetes and adults with type 2 diabetes
The FDA has given BioNJ Member Merck the greenlight on Bridion (sugammadex), which can now be used to reverse the effects of neuromuscular blockade triggered by rocuronium bromide and vecuronium bromide — neuromuscular blocking drugs used to freeze vocal cords and muscles during surgery.
BioNJ Member Sanofi is off and running with the launch of the world’s first dengue fever vaccine. Days after Sanofi received its first approval in Mexico for its pioneering dengue fever vaccine, it’s said to be in discussions to bring the vaccine to India following a successful trial on an adult population there.
BioNJ Member Bristol-Myers Squibb is lending its game-changing PD-1 drug Opdivo for a combo therapy with Neon Therapeutics‘ lead drug, NEO-PV-01, which is concentrating on the burgeoning field of neoantigen research in the hunt for a new and personalized way to spur an immune system attack on cancer.
Registration is now open for BioNJ’s 23rd Annual Gateway Gala, Dinner Meeting & Innovation Celebration scheduled for February 4, 2016. The inspirational evening will include a Keynote by the Honorable Patrick Kennedy, the presentation of the ninth annual Dr. Sol J. Barer Award to Clive Meanwell, M.D., Ph.D., Founder and CEO of The Medicines Company and the much anticipated Innovator Awards honoring companies with a footprint in New Jersey that have received a U.S. Food and Drug Administration approval in 2015 to be presented by the precious 7-year old Max Schill. See below for details!
Hope you’ll join us!
Click here to read this week’s Weekender.